These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24035443)

  • 1. Increased frequencies of Th17 cells in drug eruptions.
    Fujiyama T; Kawakami C; Sugita K; Kubo-Kabashima R; Sawada Y; Hino R; Nakamura M; Shimauchi T; Ito T; Kabashima K; Hashizume H; Tokura Y
    J Dermatol Sci; 2014 Jan; 73(1):85-8. PubMed ID: 24035443
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized fixed drug eruption caused by pazufloxacin.
    Sawada Y; Nakamura M; Tokura Y
    Acta Derm Venereol; 2011 Sep; 91(5):600-1. PubMed ID: 21597677
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed cross-reactivity between cyclophosphamide and chlorambucil.
    Ben Fredj N; Aouam K; Chaabane A; Njim L; Boughattas N
    J Clin Pharmacol; 2012 May; 52(5):771-4. PubMed ID: 21956606
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute generalized exanthematous pustulosis with histopathologic findings of lymphomatoid drug reaction.
    Llamas-Velasco M; Godoy A; Sánchez-Pérez J; García-Diez A; Fraga J
    Am J Dermatopathol; 2013 Aug; 35(6):690-1. PubMed ID: 23291582
    [No Abstract]   [Full Text] [Related]  

  • 5. Fixed drug eruption: levofloxacin, another culprit drug.
    Ben Fredj N; Aouam K; Chaabane A; Braham D; Boughattas NA
    J Clin Pharmacol; 2012 May; 52(5):775-7. PubMed ID: 21953574
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug eruptions: a review of clinical and immunological features.
    Kalish RS
    Adv Dermatol; 1991; 6():221-37; discussion 238. PubMed ID: 1824566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitization to phenacetin: immunological aspects].
    Rüegger R; Spengler H; de Weck AL; Dubach UC
    Dtsch Med Wochenschr; 1973 Apr; 98(15):762-4 passim. PubMed ID: 4266644
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug hypersensitivity: insights into pathomechanisms.
    Martin E; Mayorga C; Rodriguez R; Torres MJ; Blanca M
    Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):207-12. PubMed ID: 16156398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.
    Sawada Y; Yoshiki R; Kawakami C; Fukamachi S; Sugita K; Nakamura M; Tokura Y
    Acta Derm Venereol; 2010 Sep; 90(5):521-2. PubMed ID: 20814632
    [No Abstract]   [Full Text] [Related]  

  • 10. TH17 cells are critical for skin-specific pathological injury in acute graft-versus-host disease.
    Cheng H; Tian J; Li Z; Zeng L; Pan B; Song G; Chen W; Xu K
    Transplant Proc; 2012 Jun; 44(5):1412-8. PubMed ID: 22664026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytokine production after in vivo desensitization in an allopurinol-induced delayed allergic reaction.
    Martínez-Aranguren R; Gamboa PM; García-Lirio E; Alonso A; Sanz ML
    Ann Allergy Asthma Immunol; 2012 Apr; 108(4):280-1. PubMed ID: 22469450
    [No Abstract]   [Full Text] [Related]  

  • 13. Mononuclear-macrophages are predominantly classically activated in aminopenicillin-induced maculopapular rashes.
    Treudler R; Tebbe B; Mielcarek K; Goerdt S; Orfanos CE
    Arch Dermatol Res; 2002 Aug; 294(6):290-2. PubMed ID: 12192494
    [No Abstract]   [Full Text] [Related]  

  • 14. [Causative immunopathologic mechanisms in pediatric urticaria following primary injection with anti-hepatitis B vaccine].
    Barbaud A; Reichert-Pénétrat S; Béné MC; Kolopp-Sarda MN; Faure G; Kohler C; Schmutz JL
    Ann Dermatol Venereol; 2000; 127(6-7):662-3. PubMed ID: 11041825
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct immunofluorescence for the study of cutaneous drug eruptions.
    Gibson LE; van Hale HM; Schroeter AL
    Acta Derm Venereol; 1986; 66(1):39-44. PubMed ID: 2424213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug hypersensitivity reactions involving skin.
    Hausmann O; Schnyder B; Pichler WJ
    Handb Exp Pharmacol; 2010; (196):29-55. PubMed ID: 20020258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential immune complex deposition in mild and severe drug-induced cutaneous reactions.
    Hashizume H; Ishikawa Y; Hata A
    J Dermatol; 2024 Jun; 51(6):e201-e202. PubMed ID: 38214541
    [No Abstract]   [Full Text] [Related]  

  • 18. Psoriasiform drug eruption induced by anti-tuberculosis medication: potential role of plasma-cytoid dendritic cells.
    Park JJ; Choi YD; Lee JB; Kim SJ; Lee SC; Won YH; Yun SJ
    Acta Derm Venereol; 2010 May; 90(3):305-6. PubMed ID: 20526555
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells.
    Shiohara T; Mizukawa Y
    Eur J Dermatol; 2007; 17(3):201-8. PubMed ID: 17478380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.